Vanadium and cancer treatment: Antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line
- 1 May 2014
- journal article
- research article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 134, 106-117
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetesCoordination Chemistry Reviews, 2011
- Cyto- and genotoxicity of a vanadyl(IV) complex with oxodiacetate in human colon adenocarcinoma (Caco-2) cells: potential use in cancer therapyBioMetals, 2011
- Antidiabetic vanadium compound and membrane interfaces: interface-facilitated metal complex hydrolysisJBIC Journal of Biological Inorganic Chemistry, 2011
- Cytotoxic Property of Surfactant–Cobalt(III) Complexes on a Human Breast Cancer Cell LineArchiv der Pharmazie, 2011
- Chelation in Metal IntoxicationInternational Journal of Environmental Research and Public Health, 2010
- Vanadate-induced cell death is dissociated from H2O2 generationCell Biology and Toxicology, 2007
- Induction of COX-2 protein expression by vanadate in A549 human lung carcinoma cell line through EGF receptor and p38 MAPK-mediated pathwayBiochemical and Biophysical Research Communications, 2006
- Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potentialJBIC Journal of Biological Inorganic Chemistry, 2003
- In vitro andin vivo antineoplastic effects of ortrovanadateMolecular and Cellular Biochemistry, 1995
- Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinasesMolecular and Cellular Biochemistry, 1995